Joint Formulary & PAD

Mesna - Cytotoxic induced urothelial toxicity

You are here : Home > Formulary Search > Mesna - Cytotoxic induced urothelial toxicity

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Intravenous injection (IV)
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :
Preferred

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Mesna
Indication :
Cytotoxic induced urothelial toxicity
Group Name :
Keywords :
cyclophosphamide and ifosfamide toxicity, haemorrhagic cystitis
Brand Names Include :
Important Information :

https://www.toxbase.org/

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (1)

05 Feb 25 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

Other Indications

Below are listed other indications that Mesna is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Cytotoxic induced urothelial toxicity.

  • No records returned.